AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

INCR · NASDAQ · Drug Manufacturers - Specialty & Generic

InterCure

Produces and distributes pharmaceutical-grade medical cannabis through an integrated Israeli platform.

$5.78

After-hours close+0.06 (+1.05%)

At close$5.72(+0.70%)

Something off on this page? Send us feedback.

Profile

InterCure Ltd.INCRHealth Care

Produces, processes, exports, and distributes pharmaceutical-grade medical cannabis through Canndoc, alongside pharmacy retail operations. The business combines production and branded products with distribution partnerships and retail pharmacies in Israel and Germany.

Medical-cannabis operations run mainly through wholly owned Canndoc, Pharmazone, and Cannolam. Canndoc produces, processes, exports, and distributes pharmaceutical-grade medical cannabis, while Kan Olam, Givol, and Leon Pharm operate retail pharmacies.

The platform combines production, research and development, distribution partnerships, branded products, and pharmacy retail. Its principal operations are in Israel, with current materials also describing operations in Germany.

Production, importation, and sales at the Nir Oz facility resumed during 2025 after the October 7 disruption, while genetic-bank recovery remained an active focus. The ordinary shares remain listed and traded during Nasdaq's initial minimum-bid-price compliance period.

Company facts

CEOAlexander Rabinovich

ListedSep 1, 2021

ExchangeNASDAQ

HeadquartersHerzliya, Israel

CountryIsrael

Employees285

CIK0001857030

ISINIL0011063760

Key statistics

Market cap$68.5M

EPS (ttm)−$1.18

P/E (ttm)−4.89

ROE-8.6%

P/B0.4510

P/S0.7733

Dividend yield—

Beta0.98vs XLV 0.05

Year to date +11.1% · Average volume (30d) 39.7K

Analysts

No analyst consensus on record.

Earnings

EPS

Estimate—

Reported−$0.22

Revenue

Estimate—

Reported$15.5M

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Apr 29, 2025Q1 FY25	—	−$0.22	—	—	$15.5M	—	+3.29%
Oct 3, 2024Q2 FY24	—	$0.03	—	—	$14.9M	—	0.00%
Aug 30, 2024Q2 FY24	—	$0.00	—	—	$16.7M	—	−7.49%
May 1, 2024Q1 FY24	—	$0.00	—	$101.6M	$17.0M	−83.2%	+4.05%

View details

Financial highlights

	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25
Revenue	$19.0M	$19.0M	$21.8M	$21.8M	$23.5M	$23.5M
Gross profit	$65.6K	$65.6K	$6.7M	$6.7M	$80.3K	$80.3K
Operating income	−$13.0M	−$13.0M	$958.6K	$958.6K	−$5.5M	−$5.5M
Net income	−$11.6M	−$11.6M	−$285.8K	−$285.8K	−$5.7M	−$5.7M
Diluted EPS	−$0.26	−$0.26	−$0.01	−$0.01	−$0.11	−$0.11
Gross margin	0.3%	0.3%	30.9%	30.9%	0.3%	0.3%
Operating margin	-68.7%	-68.7%	4.4%	4.4%	-23.5%	-23.5%

Fiscal years (4-quarter sums)FY21 $73.7M · FY22 $130.4M · FY23 $119.3M · FY24 $80.1M · FY25 $90.6M

Balance sheet, Dec 31, 2025Cash & short-term investments $15.7M · Total debt $61.4M · Total assets $231.6M · Shareholders' equity $133.0M

Dividends

No dividends on record.

Ownership

Institutions 1.02%120.5K sharesInsiders 21.03%2.49M sharesOther 77.95%9.23M shares

Shares outstanding 11.85M · Float 7.61M · 64.2% free float

Insider tradesForm 4

No open-market trades in the last 12 months.